Jim Cramer Highlights “Takeover Interest” in Revolution Medicines

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the stocks Jim Cramer talked about, along with market froth. Cramer highlighted that there is a takeover interest in the company, as he commented:

Of the 32 stocks that made our froth list, seven of them were biotechs, and four of them have more than doubled. Some of these moves are easy to understand. There’s Revolution Medicines. It’s up nearly 46% after reportedly drawing takeover interest from… Merck… That could be a winner. Others have had strong clinical trial results. I like that. But again, biotech is not a good leadership group. This is a boom and bust business where gains can disappear just as quickly as they materialize. At that JPMorgan Healthcare conference I went to… I got a feeling that all sorts of biotechs were raising money here and rallying to pretty incredible valuations, often based on nothing more than a press release. That’s froth.

Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels

Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical-stage oncology company developing targeted therapies for RAS-driven cancers. RAS refers to a family of genes that produce proteins controlling cell growth and division.

While we acknowledge the risk and potential of RVMD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RVMD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.